Moberg Pharma AB (Formerly known as Moberg Derma) and Menarini Group Extend Distribution Agreement for Kerasal Nail to China

Published: Jul 22, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Moberg Pharma AB (OMX: MOB) today announced that Menarini Asia-Pacific, a member of the Menarini Group – a top 40 global pharmaceutical company – has been granted the exclusive rights to market and sell Kerasal Nail™ in China. The companies now intend to seek marketing authorization for the product in the Chinese market.

Help employers find you! Check out all the jobs and post your resume.

Back to news